当前位置:首页 - 行情中心 - 达安基因(002030) - 财务分析 - 现金流量表

达安基因

(002030)

  

流通市值:92.21亿  总市值:92.21亿
流通股本:14.03亿   总股本:14.03亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金813,245,333.21486,896,849.46240,398,300.441,439,801,857.03
  收到的税费返还490,522.75284,910.9973,494.82580,125.78
  收到其他与经营活动有关的现金522,791,928.21358,999,397.28186,932,530.27976,791,604.26
  经营活动现金流入小计1,336,527,784.17846,181,157.73427,404,325.532,417,173,587.07
  购买商品、接受劳务支付的现金326,708,733.98206,122,856.99107,300,663.12536,939,916.15
  支付给职工以及为职工支付的现金344,383,640.66245,673,189.9156,989,994.6468,265,875.59
  支付的各项税费31,500,976.5321,940,344.857,892,107.3951,340,716.27
  支付其他与经营活动有关的现金552,416,531.45383,087,370.51191,915,427.671,060,294,362.46
  经营活动现金流出小计1,255,009,882.62856,823,762.25464,098,192.782,116,840,870.47
  经营活动产生的现金流量净额81,517,901.55-10,642,604.52-36,693,867.25300,332,716.6
二、投资活动产生的现金流量:
  收回投资收到的现金604,883,045.68239,883,045.68130,370,000399,644,582.26
  取得投资收益收到的现金22,519,379.782,878,071.05578,609.0628,864,738.96
  处置固定资产、无形资产和其他长期资产收回的现金净额244,973.65245,347.3813,067.62106,176.12
  处置子公司及其他营业单位收到的现金净额00023.58
  收到的其他与投资活动有关的现金632,790,000600,000,000450,000,087.011,143,066,927.84
  投资活动现金流入小计1,260,437,399.11843,006,464.11580,961,763.691,571,682,448.76
  购建固定资产、无形资产和其他长期资产支付的现金172,105,488.81116,290,768.4232,733,690.51174,413,084.94
  投资支付的现金930,513,379.04569,513,379.04104,513,379.04371,201,735.64
  支付其他与投资活动有关的现金574,806,188.61500,000,000400,000,0001,243,460,500
  投资活动现金流出小计1,677,425,056.461,185,804,147.46537,247,069.551,789,075,320.58
  投资活动产生的现金流量净额-416,987,657.35-342,797,683.3543,714,694.14-217,392,871.82
三、筹资活动产生的现金流量:
  取得借款收到的现金82,511,520.0943,360,867.527,790,010147,852,756.85
  收到其他与筹资活动有关的现金14,900,0009,900,000046,800,000
  筹资活动现金流入小计97,411,520.0953,260,867.527,790,010194,652,756.85
  偿还债务支付的现金133,889,726103,633,32653,647,326357,667,421.92
  分配股利、利润或偿付利息支付的现金2,828,231.182,042,491.431,025,509.7127,879,255.95
  支付其他与筹资活动有关的现金1,002,486.86743,531.38815,335.6915,061,103.07
  筹资活动现金流出小计137,720,444.04106,419,348.8155,488,171.4400,607,780.94
  筹资活动产生的现金流量净额-40,308,923.95-53,158,481.31-27,698,161.4-205,955,024.09
四、汇率变动对现金及现金等价物的影响-887,822.91-429,638.66-100,827.821,112,584.86
五、现金及现金等价物净增加额-376,666,502.66-407,028,407.84-20,778,162.33-121,902,594.45
  加:期初现金及现金等价物余额867,371,878.26867,371,878.26867,371,878.26989,274,472.71
  期末现金及现金等价物余额490,705,375.6460,343,470.42846,593,715.93867,371,878.26
补充资料:
  净利润--190,124,632.54--939,112,861.02
  资产减值准备-5,828,434.13-75,039,742.89
  固定资产和投资性房地产折旧-92,464,575.59-227,544,629.61
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-92,464,575.59-227,544,629.61
  无形资产摊销-69,142,480.83-116,514,359.09
  长期待摊费用摊销-5,619,533.75-11,371,952.54
  处置固定资产、无形资产和其他长期资产的损失--476,575.74--9,096,715.23
  固定资产报废损失-4,075,401.17-1,762,355.5
  公允价值变动损失--85,568,280.89-175,745,759.4
  财务费用-2,100,374.22-9,744,538.33
  投资损失--4,777,877.08-253,838,060.16
  递延所得税--33,697,862.43--148,113,569.96
  其中:递延所得税资产减少--47,072,964.16--129,498,953.04
    递延所得税负债增加-13,375,101.73--18,614,616.92
  存货的减少-11,169,125.98-80,688,743.16
  经营性应收项目的减少-133,877,198.72-745,693,804.95
  经营性应付项目的增加--193,221,927.97--715,417,059.2
  其他-0-0
  债务转为资本-0-0
  一年内到期的可转换公司债券-0-0
  融资租入固定资产-0-0
  不涉及现金收支的投资和筹资活动金额其他项目---13,781,763.55
  现金的期末余额-460,343,470.42-867,371,878.26
  减:现金的期初余额-867,371,878.26-989,274,472.71
  加:现金等价物的期末余额-0-0
  减:现金等价物的期初余额-0-0
  现金及现金等价物的净增加额--407,028,407.84--121,902,594.45
公告日期2025-10-312025-08-302025-04-302025-03-29
审计意见(境内)标准无保留意见
TOP↑